Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 10, 2014
For more info, visit http://www.bio-rad.com/yt/10/QX200-Dr... Researchers at UC Davis applied Droplet Digital PCR (ddPCR™) technology to determine copy number variation (CNV) and to characterize the deletion end points of the region of chromosome 22 that is deleted in 22q11DS. They found that ddPCR assays rapidly produced high-resolution copy number change measurements and defined the position of the deletion end points with great sensitivity and specificity.
The Droplet Digital PCR system allows for the quantification of target DNA with unrivaled precision by partitioning samples into 20,000 nanoliter-sized droplets. After PCR on a thermal cycler, PCR-positive and PCR-negative droplets are counted to provide absolute quantification of the target DNA. Since its introduction two years ago, ddPCR technology has transformed multiple fields of research, including infectious disease, cancer biomarker analysis, and genomic variation analysis.
Presenter: Vicki Hwang Vicki is a graduate student in Dr. Flora Tassone's laboratory at UC Davis. The Tassone lab focuses on a number of neuro-developmental disorders including Autism Spectrum Disorders and 22q11.2 deletion syndrome.
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.